Snow Capital Management LP Upped Apple (AAPL) Position By $1.05 Million; Last Week Johnson & Johnson (JNJ) Coverage

April 19, 2018 - By Hazel Jackson

Johnson & Johnson (NYSE:JNJ) Logo

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 95 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Friday, March 23 by Jefferies. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by S&P Research on Wednesday, October 14. BMO Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Thursday, August 31. BMO Capital Markets has “Buy” rating and $145.0 target. The rating was initiated by Citigroup on Monday, September 25 with “Hold”. The firm earned “Neutral” rating on Monday, October 5 by Piper Jaffray. JP Morgan downgraded the stock to “Neutral” rating in Tuesday, January 2 report. The firm has “Buy” rating given on Monday, February 26 by Jefferies. BTIG Research maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, January 23 with “Sell” rating. As per Friday, July 21, the company rating was downgraded by BTIG Research. On Thursday, August 4 the stock rating was maintained by Jefferies with “Hold”. See Johnson & Johnson (NYSE:JNJ) latest ratings:

12/04/2018 Broker: Credit Suisse Rating: Buy New Target: $154.0000 Upgrade
13/04/2018 Broker: Jefferies Rating: Buy New Target: $153.0000 Maintain
10/04/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $148 New Target: $143 Maintain
23/03/2018 Broker: Jefferies Rating: Buy New Target: $161.0000 Maintain
26/02/2018 Broker: Jefferies Rating: Buy New Target: $165.0 Maintain
27/02/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $150 New Target: $146 Maintain
06/02/2018 Broker: Wells Fargo Rating: Buy New Target: $160.0 Maintain
23/01/2018 Broker: BTIG Research Rating: Sell New Target: $110.0 Maintain
24/01/2018 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Hold Old Target: $142 New Target: $145 Maintain
16/01/2018 Broker: Jefferies Rating: Buy New Target: $170.0 Maintain

Snow Capital Management Lp increased Apple Inc (AAPL) stake by 42.83% reported in 2017Q4 SEC filing. Snow Capital Management Lp acquired 6,200 shares as Apple Inc (AAPL)’s stock declined 3.81%. The Snow Capital Management Lp holds 20,677 shares with $3.50M value, up from 14,477 last quarter. Apple Inc now has $879.28 billion valuation. The stock decreased 2.56% or $4.55 during the last trading session, reaching $173.29. About 12.49M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 19.49% since April 19, 2017 and is uptrending. It has outperformed by 7.94% the S&P500.

Among 54 analysts covering Apple Inc. (NASDAQ:AAPL), 35 have Buy rating, 1 Sell and 18 Hold. Therefore 65% are positive. Apple Inc. had 394 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Wednesday, September 6 by Nomura. The stock of Apple Inc. (NASDAQ:AAPL) has “Overweight” rating given on Monday, December 14 by Barclays Capital. The rating was maintained by Drexel Hamilton with “Buy” on Wednesday, August 23. Rosenblatt initiated the shares of AAPL in report on Wednesday, September 9 with “Buy” rating. The company was maintained on Friday, October 27 by Drexel Hamilton. The firm has “Buy” rating by Bernstein given on Wednesday, September 13. Needham initiated Apple Inc. (NASDAQ:AAPL) rating on Wednesday, April 6. Needham has “Strong Buy” rating and $150 target. Macquarie Research maintained it with “Outperform” rating and $148 target in Friday, January 20 report. Oppenheimer maintained Apple Inc. (NASDAQ:AAPL) on Tuesday, June 6 with “Hold” rating. RBC Capital Markets maintained Apple Inc. (NASDAQ:AAPL) rating on Wednesday, February 1. RBC Capital Markets has “Outperform” rating and $140 target.

Investors sentiment increased to 0.73 in Q4 2017. Its up 0.03, from 0.7 in 2017Q3. It increased, as 50 investors sold AAPL shares while 1023 reduced holdings. 151 funds opened positions while 637 raised stakes. 2.98 billion shares or 0.18% more from 2.97 billion shares in 2017Q3 were reported. Toronto Dominion Bank owns 3.11 million shares for 1.56% of their portfolio. 1,111 are held by Interactive Advsrs. Fuller Thaler Asset Management invested in 81,488 shares. New England Rech holds 1.51% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 12,463 shares. Westover Cap Advisors Limited Liability Corporation accumulated 34,632 shares. Lpl Fincl Limited Liability Co stated it has 1% in Apple Inc. (NASDAQ:AAPL). Lodestar Inv Counsel Limited Liability Com Il has 3.45% invested in Apple Inc. (NASDAQ:AAPL) for 176,850 shares. Telemark Asset Mngmt Limited Liability Corp invested in 2.49% or 75,000 shares. Sadoff Inv has invested 0.26% of its portfolio in Apple Inc. (NASDAQ:AAPL). Bridgecreek Inv Management Ltd Liability Com holds 3.63% or 91,184 shares in its portfolio. Barclays Plc owns 6.51 million shares or 0.9% of their US portfolio. Finance Counselors Inc, a Missouri-based fund reported 243,155 shares. First Bancshares Of Hutchinson stated it has 0.44% of its portfolio in Apple Inc. (NASDAQ:AAPL). Kansas-based Intrust Comml Bank Na has invested 2.21% in Apple Inc. (NASDAQ:AAPL). Vigilant Cap Mngmt Limited Company holds 116,845 shares.

Since December 7, 2017, it had 0 buys, and 4 selling transactions for $19.89 million activity. 69,491 Apple Inc. (NASDAQ:AAPL) shares with value of $11.56 million were sold by SCHILLER PHILIP W. Riccio Daniel J. sold $2.94 million worth of stock.

Snow Capital Management Lp decreased Centene Corp (NYSE:CNC) stake by 120,933 shares to 444,421 valued at $44.83M in 2017Q4. It also reduced Voya Financial Inc (NYSE:VOYA) stake by 186,479 shares and now owns 1.37 million shares. Pvh Corp (NYSE:PVH) was reduced too.

Johnson & Johnson, together with its subsidiaries, researches and develops, makes, and sells various products in the health care field worldwide. The company has market cap of $342.65 billion. It operates through three divisions: Consumer, Pharmaceutical, and Medical Devices. It has a 269.47 P/E ratio. The Consumer segment offers baby care products under the JOHNSONÂ’S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONÂ’S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It improved, as 35 investors sold Johnson & Johnson shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Curbstone Management Corp reported 15,225 shares. 38,037 were accumulated by Investec Asset Mngmt North America. M Kraus And stated it has 3.68% in Johnson & Johnson (NYSE:JNJ). Wms Partners Ltd Limited Liability Company holds 192,158 shares or 3.02% of its portfolio. Independent Investors holds 4.82% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 88,749 shares. Miracle Mile Ltd Liability Corp holds 3,310 shares or 0.07% of its portfolio. 114,044 were accumulated by Jones Fin Cos Lllp. Fulton Fincl Bank Na invested in 0.65% or 65,471 shares. Strs Ohio reported 1.02% in Johnson & Johnson (NYSE:JNJ). Glg Lc invested 1.34% in Johnson & Johnson (NYSE:JNJ). Forest Hill Capital Limited Liability reported 3,050 shares or 0.12% of all its holdings. Northrock Prns Limited Com reported 0.07% in Johnson & Johnson (NYSE:JNJ). Hirtle Callaghan And Com Limited Liability Corp holds 0.19% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 14,600 shares. Zacks Invest Mngmt reported 2.03% stake. Vision has invested 0.74% in Johnson & Johnson (NYSE:JNJ).

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>